{"result": {"id": "7d9f2938-d070-425d-bdd7-99adc4bf00a0", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN<|>ORGANIZATION<|>MTP is located in liver and intestinal cells' endoplasmic reticulum and transfers triglycerides and cholesterol to ApoB>  \n##  \n(\"entity\"<|>LOMITAPIDE<|>ORGANIZATION<|>Lomitapide is an MTP inhibitor that significantly reduces LDL-C levels>  \n##  \n(\"entity\"<|>APOB<|>ORGANIZATION<|>ApoB is a protein involved in lipid transport that interacts with MTP>  \n##  \n(\"entity\"<|>CHINESE JOURNAL OF GENERAL PRACTICE<|>ORGANIZATION<|>The journal publishing this consensus on mixed hyperlipidemia diagnosis and treatment>  \n##  \n(\"relationship\"<|>LOMITAPIDE<|>MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN<|>Lomitapide inhibits MTP to reduce LDL-C levels<|>8>  \n##  \n(\"relationship\"<|>MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN<|>APOB<|>MTP transfers lipids to ApoB during lipoprotein formation<|>8>  \n##  \n(\"relationship\"<|>VOLANESORSEN<|>TG<|>Volanesorsen reduces TG levels by targeting ApoCIII<|>7>  \n##  \n(\"relationship\"<|>EVINACUMAB<|>LDL?C<|>Evinacumab significantly lowers LDL-C levels through its mechanism of action<|>8>  \n##  \n(\"relationship\"<|>MK?0616<|>LDL?C<|>MK-0616 lowers LDL-C levels by inhibiting PCSK9<|>8>  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752166451, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 396, "prompt_tokens": 3200, "total_tokens": 3596, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3136}, "prompt_cache_hit_tokens": 3136, "prompt_cache_miss_tokens": 64}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ，ULN 参考值上限，CK 肌酸激酶；需注意出现严重药物不良反应者应考虑转诊 至上级医疗机构\n图3  降脂药物应用期间不良反应的处理流程\n\n\n\n· 914   ·                                                       中华全科医师杂志 2024 年 9 月第 23 卷第 9 期    Chin J Gen Pract, September 2024, Vol. 23, No. 9\n\n\n抑制剂，可在高强度他汀类药物治疗的基础上进一 步降低 LDL?C 水平，且安全性和耐受性良好［61］。\n　　微 粒 体 甘 油 三 酯 转 运 蛋 白（microsomal triglyceride transfer protein，MTP）主要位于肝细胞 和小肠细胞内质网，通过将甘油三酯和胆固醇从细 胞膜转移到新生的 ApoB 发挥作用 。洛美他派是一 种 MTP 抑制剂，可显著降低 LDL?C 水平［62］。\n（二）单克隆抗体类药物\n　　　MK?0616 是一种新型口服 PCSK9 抑制剂，通过  抑制 PCSK9 与 LDL?R 结合 ，降低血液中 LDL?C 水  平 。2b 期临床试验显示其疗效和安全性良好［63］。 evinacumab 是一种针对血管生成素样蛋白 3 的单克  隆抗体 ，3 期临床试验显示其降低LDL?C 的效果  显著［64］。\n（三）反义寡核苷酸类药物\n　　volanesorsen 是一种以 ApoCⅢ为靶点的反义寡 核苷酸，通过抑制 ApoCⅢ合成，降低 TG 水平［65］。\n（四）降 Lp（a）类药物\n　　　近年来，关于降 Lp（a）的药物研究取得了一些  进展 。Lp（a）是一种与 LDL?C 结构相似的脂蛋白， Lp（a）水平升高是 ASCVD 的独立危险因素 。将目  前针对 Lp（a）的降脂药物汇总如表 6［66］。\n（五）PCSK9 基因编辑治疗\n　　　通过基因编辑技术可实现永久抑制致病基因， 目前包括 CRISPR?Cas 碱基编辑和 CRISPR?Cas 基  因编辑两种方法［67］。通过直接修改基因序列实现  永 久 性 抑 制 PCSK9，这 为 降 脂 治 疗 提 供 了 新 的  可能［68］。\n（六）研究方向\n　　　未来的研究可深入探讨混合型高脂血症的病 因学，特别是分子遗传学基础和代谢特征 。随着对 残余风险认识的增加，血脂指标的全面评估及全程 管 理 将 成 为 ASCVD 研 究 的 新 焦 点 。 此 外 ，除 LDL?C 以外，TG、TC、Lp（a）及非 HDL?C 的调控也越 来越受到重视。\n\n\n　　　总之，本共识综合了最新的循证医学证据和 相关指南，为混合型高脂血症的诊断、治疗和随访 管理提供了建议 。本共识强调综合性管理的重要 性，包括生活方式干预、药物治疗以及定期血脂监 测 。对于基层医务工作者而言，掌握并应用本共 �\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>MK?0616<|>ORGANIZATION<|>MK?0616 is a novel oral PCSK9 inhibitor that lowers LDL-C levels by inhibiting PCSK9 binding to LDL-R, with good efficacy and safety shown in phase 2b clinical trials>  \n##  \n(\"entity\"<|>EVINACUMAB<|>ORGANIZATION<|>Evinaucmab is a monoclonal antibody targeting angiopoietin-like protein 3, which significantly reduces LDL-C levels as demonstrated in phase 3 clinical trials>  \n##  \n(\"entity\"<|>VOLANESORSEN<|>ORGANIZATION<|>Volanesorsen is an antisense oligonucleotide targeting ApoCIII, which reduces TG levels by inhibiting ApoCIII synthesis>  \n##  \n(\"entity\"<|>CRISPR?CAS<|>ORGANIZATION<|>CRISPR-Cas is a gene editing technology that can permanently inhibit disease-causing genes, offering new possibilities for lipid-lowering therapy>  \n##  \n(\"entity\"<|>LDL?C<|>ORGANIZATION<|>LDL-C is a type of cholesterol that is a major target in lipid-lowering therapies>  \n##  \n(\"entity\"<|>TG<|>ORGANIZATION<|>TG (Triglycerides) are a type of fat in the blood that is increasingly recognized as important in lipid management>  \n##  \n(\"entity\"<|>LP(A)<|>ORGANIZATION<|>Lp(a) is a lipoprotein similar to LDL-C, and elevated levels are an independent risk factor for ASCVD>  \n##  \n(\"entity\"<|>PCSK9<|>ORGANIZATION<|>PCSK9 is a protein targeted by inhibitors to lower LDL-C levels>  \n##  \n(\"relationship\"<|>MK?0616<|>PCSK9<|>MK?0616 is a PCSK9 inhibitor that works by blocking PCSK9's interaction with LDL-R<|>8>  \n##  \n(\"relationship\"<|>EVINACUMAB<|>ANGIOPOIETIN-LIKE PROTEIN 3<|>Evinacumab targets angiopoietin-like protein 3 to reduce LDL-C levels<|>8>  \n##  \n(\"relationship\"<|>VOLANESORSEN<|>APOCIII<|>Volanesorsen inhibits ApoCIII synthesis to lower TG levels<|>8>  \n##  \n(\"relationship\"<|>CRISPR?CAS<|>PCSK9<|>CRISPR-Cas gene editing can permanently inhibit PCSK9, offering a potential long-term solution for lipid management<|>7>  \n##  \n(\"relationship\"<|>LP(A)<|>ASCVD<|>Elevated Lp(a) levels are an independent risk factor for ASCVD<|>7>  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_54805e8fd1f02d637efd523f491ba7f6ed79ce5e6bb589e9afbc78b5b2988501_v2"}